Company news
Faron Pharmaceuticals Oy news in 2019
Faron Pharmaceuticals Oy's news releases, calls and decks from 2019, newest first.
Update on Traumakine drug substance manufacturing
December 30, 2019
Matins Trial Update
December 11, 2019
Liquidity providing agreement
November 29, 2019
FDA has approved Faron's Clevegen IND
November 28, 2019
Faron´s financial calendar for 2020
November 27, 2019
Application to Nasdaq First North Growth Market
November 21, 2019
Registration of Shares
November 12, 2019
Results of Placing and Issue Price
November 8, 2019
Proposed Placing and Financial Adviser Appointment
November 7, 2019
Statement regarding Price Movement
November 1, 2019
MATINS poster presentation at ESMO Congress
September 30, 2019
Interim results
September 23, 2019
MATINS study selected for ESMO 2019
September 2, 2019
Result of Open Offer and Further Subscription
August 27, 2019
Notice of Interim Results
August 16, 2019
Subscription and Open Offer
August 5, 2019
MATINS study update
July 12, 2019
Phase II INFORAAA study update
June 26, 2019
Final results from YODA study
June 14, 2019
AGM update, Board & management changes
May 24, 2019
Share Subscription and Issue of Equity
May 14, 2019
Notice of AGM
May 7, 2019
Results from the Japanese Phase III study
April 29, 2019
First expansion cohort for MATINS trial part 2
April 11, 2019
Notice of Results
April 5, 2019
Results of the Placing and Subscription
March 28, 2019
Result of Placing and Issue Price
March 26, 2019
New data published by Clinical Cancer Research
February 13, 2019
Decks in 2019
- Shareholder Meeting (May 2019)
Shareholder meeting · 26 slides · May 28, 2019